Pharmaceuticals

Revenue of the Menopausal Disorder Treatment Market Predicted to Achieve $16.26 Billion by 2030, Driven by 7.2% CAGR

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the menopausal disorder treatment market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Menopausal Disorder Treatment Market expected to grow between 2026 and 2030?

The menopausal disorder treatment market size has seen strong growth in recent years. It is anticipated to increase from $11.47 billion in 2025 to $12.32 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. The expansion observed historically is linked to a growing aging female population, widespread use of hormone replacement therapy, an increase in the diagnosis of menopausal symptoms, the expansion of gynecology care services, and improved healthcare access for women.

The menopausal disorder treatment market is projected to experience substantial expansion over the upcoming years. By 2030, this market is anticipated to reach $16.26 billion, exhibiting a compound annual growth rate (CAGR) of 7.2%. This anticipated growth during the forecast period stems from factors such as an increased demand for safer menopause therapies, a heightened emphasis on customized treatment strategies, growing recognition of the risks associated with long-term hormone replacement therapy (HRT), the proliferation of digital platforms dedicated to women’s health, and the rising uptake of preventive women’s healthcare. Key trends expected within this period encompass a growing inclination towards non-hormonal menopause solutions, a surge in the adoption of personalized hormone replacement therapy, broader utilization of lifestyle and behavioral modifications, an expansion in the availability of herbal and natural menopause remedies, and enhanced understanding of menopause symptom management.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24318&type=smp

Which Drivers Are Influencing Market Acceleration In The Menopausal Disorder Treatment Market?

The increasing need for hormone replacement therapies (HRT) is anticipated to drive expansion in the menopausal disorder treatment market moving ahead. HRT is a medical approach involving the supplementation or substitution of hormones to ease symptoms linked to menopause or hormonal imbalances. The rise in hormone replacement therapies stems from heightened awareness and a call for efficient handling of menopausal symptoms and hormone imbalances. HRT addresses menopausal disorder by directly restoring estrogen and progesterone levels, thereby assisting in re-establishing hormonal equilibrium and mitigating troublesome symptoms like hot flashes, night sweats, and mood swings, consequently enhancing the quality of life. For example, in October 2024, the NHS Business Services Authority (NHSBSA), a UK-based support services provider, reported a 22% increase in prescribed HRT items, reaching 13 million. This was alongside a 12% rise in identified patients, moving from 2.3 million in 2022/23 to 2.6 million in 2023/24. Consequently, the expanding demand for hormone replacement therapies is fueling the growth of the menopausal disorder treatment market.

What Segments Are Identified Within The Structure Of The Menopausal Disorder Treatment Market?

The menopausal disorder treatment market covered in this report is segmented –

1) By Treatment Type: Hormone Replacement Therapy, Non-Hormonal Treatment, Herbal Supplements, Lifestyle Modifications

2) By Stages: Menopause, Postmenopause, Perimenopause

3) By Application: Hot Flashes, Night Sweats, Mood Swings, Vaginal Dryness

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Hormone Replacement Therapy (HRT): Estrogen Therapy, Progesterone Therapy, Combination Therapy, Transdermal Patches, Vaginal Estrogen, Oral Tablets

2) By Non-Hormonal Treatment: Selective Estrogen Receptor Modulators (SERMs), Antidepressants, Gabapentin, Clonidine, Bisphosphonates, Calcium And Vitamin D Supplements

3) By Herbal Supplements: Black Cohosh, Red Clover, Dong Quai, Ginseng, Soy Isoflavones, Flaxseed

4) By Lifestyle Modifications: Dietary Changes, Regular Physical Exercise, Stress Management Techniques, Cognitive Behavioral Therapy (CBT), Smoking Cessation, Sleep Hygiene Practices

What Trends Are Driving The Growth Trajectory Of The Menopausal Disorder Treatment Market?

Leading firms in the menopausal disorder treatment market are creating new nonhormonal neurokinin 3 (NK3) receptor antagonist medications designed for the effective management of vasomotor symptoms, bypassing the need for hormone therapy. These cutting-edge nonhormonal neurokinin 3 (NK3) receptor antagonist treatments operate by obstructing NK3 receptors, offering a hormone-free approach to alleviate menopausal symptoms. As an illustration, in December 2023, Astellas Pharma Inc., a pharmaceutical company from Japan, obtained approval from the European Commission for its product, Veozah (fezolinetant). This non-hormonal NK3 receptor antagonist is intended for addressing moderate to severe vasomotor symptoms (VMS), including hot flashes and night sweats, in women experiencing menopause. Its mechanism involves targeting specific neurons within the brain’s temperature regulation center, thereby diminishing the occurrence and severity of these symptoms.

Which Leading Companies Dominate The Menopausal Disorder Treatment Market Share?

Major companies operating in the menopausal disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co Inc., Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Sanofi SA, AstraZeneca plc, Eli Lilly and Company, Novo Nordisk A/S, Abbott Laboratories, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Ipsen SA, Dr. Reddy’s Laboratories Ltd., Theramex, Besins Healthcare, Mithra Pharmaceuticals, Duchesnay USA, Fervent Pharmaceuticals, Joylux Inc., TherapeuticsMD Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/menopausal-disorder-treatment-global-market-report

How Does The Menopausal Disorder Treatment Market Perform Across Major Global Regions?

North America was the largest region in the menopausal disorder treatment market in 2025. The regions covered in the menopausal disorder treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Menopausal Disorder Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24318&type=smp

Browse Through More Reports Similar to the Global Menopausal Disorder Treatment Market 2026, By The Business Research Company

Menopausal Hot Flashes Market Report 2026

https://www.thebusinessresearchcompany.com/report/menopausal-hot-flashes-global-market-report

Menopause Market Report 2026

https://www.thebusinessresearchcompany.com/report/menopause-global-market-report

Hormone Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795